United States · Funded startup

Who invested in Prelude Therapeutics

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Raised 7 months ago

Funding summaryUpdated 26 Oct 2026

$150Mraised across 2 rounds since 2019, from 2 sources

$60MSeries B$90MRound
Latest round
Round, $90MApr 2026
Step-upi
1.5×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20192020202120222023202420252026
$60MSeries B$90MRound
First round
Series B, $60M
Jun 2019
Biggest round
$90M
Round · Apr 2026
Between rounds
6.8 years
from the last two

The rounds

  1. Apr 2026
    Round$90M2 new1 returning

    Source recorded

  2. Jun 2019
    Series B$60M1 new

    Reported by FinSMEsSEC filing: $30M sold, first sale May 2019

Founders and team

From Prelude Therapeutics's own website and the SEC filings it signed: 8 on the team.

  • Bryant LimChief Financial Officer & Chief Legal Officer
  • Andrew C. CombsExecutive Officeri
  • Brian C. PiperExecutive Officeri
  • Christopher C. PierceExecutive Officeri
  • David C. MauroExecutive Officeri
  • Deborah C. MorosiniExecutive Officeri
  • Krishna VaddiExecutive Officer, Directori
  • Peggy C. ScherleExecutive Officeri

On the board, as filediDavid BonitaKelvin NeuMardi C. DierPaul FriedmanVictor Sandor

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

OrbiMedPrivate equity2rounds
RA Capital ManagementPrivate equity1round
FidelityVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Prelude Therapeutics

Who invested in Prelude Therapeutics?

Prelude Therapeutics's investors include OrbiMed, RA Capital Management and Fidelity.

How much has Prelude Therapeutics raised?

Prelude Therapeutics has raised $150M across 2 rounds since 2019.

When did Prelude Therapeutics last raise?

Prelude Therapeutics's most recent round was an Undisclosed round of $90M in Apr 2026.

What was Prelude Therapeutics's biggest round?

Its most recent round, $90M in Apr 2026, is also its largest on record.

Who backed Prelude Therapeutics first?

Prelude Therapeutics's first round on record, in Jun 2019, was backed by OrbiMed.

What stage is Prelude Therapeutics at?

Prelude Therapeutics's latest named round is an Undisclosed round, in Apr 2026.

Where is Prelude Therapeutics based?

Prelude Therapeutics is based in the United States.

Companies like Prelude Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.